Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media

K Ghani, S Cottin, A Kamen, M Caruso - Gene therapy, 2007 - nature.com
Several patients with severe combined immunodeficiency-X1 disease and adenosine
deaminase deficiency have been cured by retroviral-mediated gene therapy. Despite the …
被引用次数：67 相关文章
[PDF] researchgate.net

[PDF][PDF] Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media

K Ghani, S Cottin, A Kamen, M Caruso - Gene Therapy, 2007 - researchgate.net
The retroviral vector derived from Moloney murine leukemia virus (MLV) was the first viral
vector developed for gene therapy, and it is still the vector of choice in many clinical trials for …

Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.

K Ghani, S Cottin, A Kamen, M Caruso - Gene Therapy, 2007 - search.ebscohost.com
Several patients with severe combined immunodeficiency-X1 disease and adenosine
deaminase deficiency have been cured by retroviral-mediated gene therapy. Despite the …

Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media

K Ghani, S Cottin, A Kamen, M Caruso - Gene therapy, 2007 - pubmed.ncbi.nlm.nih.gov
Several patients with severe combined immunodeficiency-X1 disease and adenosine
deaminase deficiency have been cured by retroviral-mediated gene therapy. Despite the …
[PDF] academia.edu

[PDF][PDF] Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media

K Ghani, S Cottin, A Kamen, M Caruso - Gene Therapy, 2007 - academia.edu
The retroviral vector derived from Moloney murine leukemia virus (MLV) was the first viral
vector developed for gene therapy, and it is still the vector of choice in many clinical trials for …

Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media

K Ghani, S Cottin, A Kamen, M Caruso - Gene Therapy, 2007 - go.gale.com
Several patients with severe combined immunodeficiency-X1 disease and adenosine
deaminase deficiency have been cured by retroviral-mediated gene therapy. Despite the …

[引用][C] Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media

K GHANI, S COTTIN, A KAMEN… - Gene therapy …, 2007 - pascal-francis.inist.fr
Generation of a high-titer packaging cell line for the production of retroviral vectors in
suspension and serum-free media CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.

K Ghani, S Cottin, A Kamen, M Caruso - Gene Therapy, 2007 - europepmc.org
Several patients with severe combined immunodeficiency-X1 disease and adenosine
deaminase deficiency have been cured by retroviral-mediated gene therapy. Despite the …

Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.

K Ghani, S Cottin, A Kamen, M Caruso - Gene Therapy, 2007 - search.ebscohost.com
Several patients with severe combined immunodeficiency-X1 disease and adenosine
deaminase deficiency have been cured by retroviral-mediated gene therapy. Despite the …

[引用][C] Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media

K Ghani, S Cottin, A Kamen, M Caruso - Gene Therapy, 2007 - Nature Publishing Group